Denna sida på svenska
Loading profile information...

Publications

Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy
Valiga Study Group Of The Era-edta Immunonephrology Working Group, Coppo R, Peruzzi L, Loiacono E, Bergallo M, Krutova A, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2018;():-

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis
Lundberg S, Westergren E, Smolander J, Bruchfeld A
Clinical kidney journal 2017;10(1):20-26

Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers
Jarrick S, Lundberg S, Welander A, Fored Cm, Ludvigsson Jf
Clinical epidemiology 2017;9():67-73

Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort
Coppo R, Lofaro D, Camilla Rr, Bellur S, Cattran D, Cook Ht, et al
Pediatric nephrology (Berlin, Germany) 2017;32(1):193-194

Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort
Coppo R, Lofaro D, Camilla Rr, Bellur S, Cattran D, Cook Ht, et al
Pediatric nephrology (Berlin, Germany) 2017;32(1):139-150

Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption
Flam B, Sackey P, Berge A, Zachau Ac, Brink B, Lundberg S
Journal of nephrology 2016;29(5):711-4

Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy
Era-edta Immunonephrology Working, Feehally J, Coppo R, Troyanov S, Bellur Ss, Cattran D, et al
NEPHRON 2016;132(1):15-24

Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease
Ohlsson S, Herlitz H, Lundberg S, Selga D, Mölne J, Wieslander J, et al
American journal of kidney diseases : the official journal of the National Kidney Foundation 2014;63(2):289-93

Risk of renal disease in patients with both type 1 diabetes and coeliac disease
Mollazadegan K, Fored M, Lundberg S, Ludvigsson J, Ekbom A, Montgomery Sm, et al
Diabetologia 2014;57(7):1339-45

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Valiga Study Of The Era-edta Immunonephrology Working Group, Coppo R, Troyanov S, Bellur S, Cattran D, Cook Ht, et al
Kidney international 2014;86(4):828-36

Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population
Vuong Mt, Lundberg S, Gunnarsson I, Wramner L, Lundström E, Fernström A, et al
Human immunology 2013;74(8):957-60

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy
Lundberg S, Qureshi Ar, Olivecrona S, Gunnarsson I, Jacobson Sh, Larsson Te
Clinical journal of the American Society of Nephrology : CJASN 2012;7(5):727-34

Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy
Lundberg S, Gunnarsson I, Jacobson Sh
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY 2012;46(2):148-55

Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy
Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson Sh
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(5):1916-23

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
Vuong Mt, Hahn-zoric M, Lundberg S, Gunnarsson I, Van Kooten C, Wramner L, et al
KIDNEY INTERNATIONAL 2010;78(12):1281-7

Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease
Lundberg S, Lundahl J, Gunnarsson I, Jacobson Sh
CLINICAL NEPHROLOGY 2010;73(3):221-8

Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy - No Support of an Overlap
Mai Tv, Gunnarsson I, Lundberg S, Svenungsson E, Wramner L, Fernstrom A, et al
PLOS ONE 2010;5(5):e10559-

Genetic Study of IgA Nephropathy and Lupus Nephritis: No Overlap in Genetic Risk Factors
Vuong M, Gunnarsson I, Lundberg S, Wramner L, Fernstrom A, Syvanen Ac, et al
CLINICAL IMMUNOLOGY 2010;:S114-S114

Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial
European Vasculitis Study Group (euvas), Hiemstra Tf, Walsh M, Mahr A, Savage Co, De Groot K, et al
JAMA 2010;304(21):2381-8

Genetic variation in the transforming growth factor-beta 1 gene is associated with susceptibility to IgA nephropathy
Mai Tv, Lundberg S, Gunnarsson I, Wramner L, Seddighzadeh M, Hahn-zoric M, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2009;24(10):3061-7

Evidence for genetic regulation of Fc alpha receptor (CD89) expression: Study of soluble CD89 in plasma of IgA nephropathy patients and healthy controls
Hahn-zoric M, Vuong M, Lundberg S, Wramner L, Ahlmen J, Hanson La, et al
CLINICAL IMMUNOLOGY 2008;:S151-S151

Show all publications